NBIX vs PLRX · P/E 45, rev $1.77B vs $77.3M cap
Neurocrine Biosciences Inc (NBIX) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the NBIX and PLRX stock pages for the full models.
Not investment advice.